Literature DB >> 29696399

Levetiracetam-induced rhabdomyolysis: the first Italian case.

Eugenia Rota1, Luciano Arena2, Lorenzo Celli2, Lucia Testa2, Nicola Morelli3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29696399     DOI： 10.1007/s10072-018-3421-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  Rhabdomyolysis associated with levetiracetam administration.

Authors:  Rodica Di Lorenzo; Yuebing Li
Journal:  Muscle Nerve       Date:  2017-03-23       Impact factor: 3.217

2.  Levetiracetam-induced rhabdomyolysis: Analysis of reports from the Food and Drug Administration's Adverse Event Reporting System database.

Authors:  Carla Carnovale; Marta Gentili; Stefania Antoniazzi; Emilio Clementi; Sonia Radice
Journal:  Muscle Nerve       Date:  2017-09-30       Impact factor: 3.217

3.  Levetiracetam Induced Increase in Creatine Phosphokinase Levels.

Authors:  Naila Shahbaz; Syed Muneeb Younus; Sohaib Ahmed Khan; Qurrat -Ul- Ain; Mudassir Ahmed Khan; Mohammad Hassan Memon
Journal:  J Coll Physicians Surg Pak       Date:  2017-03       Impact factor: 0.711

Review 4.  Rhabdomyolysis: review of the literature.

Authors:  R Zutt; A J van der Kooi; G E Linthorst; R J A Wanders; M de Visser
Journal:  Neuromuscul Disord       Date:  2014-05-21       Impact factor: 4.296

5.  Creatine phosphokinase elevation exacerbated by levetiracetam therapy.

Authors:  Julia E Isaacson; Dongwhoon J Choe; Michael J Doherty
Journal:  Epilepsy Behav Case Rep       Date:  2014-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.